Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using the patient's own T-cells to target tumors.
Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors. Researchers at the Johns ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback